Skip to content

VIRCO PHARMA

Active
Private limited companyfounded 201610 yrs activeKasteelstraat 1A, 1560 Hoeilaart, BelgiumKBO/BCE: BE 0660.706.392
Summary

The computed 12-month bankruptcy probability of VIRCO PHARMA is 3.4% (moderate). The 2024 annual accounts show equity of €409,532 and a net result of €43,455. Equity is growing by ~49.3% per year across the filed fiscal years. Its solvency ranks better than 26% of 9633 sector peers (fiscal year 2024). The company has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals.

Risk analysisWatch ReportCompare
VIRCO PHARMAActiveChecked score 50/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
#10 company by total assets in Hoeilaart, Wholesale and retail trade sector1 site
Size
€2.2mtotal assets 2024
Staff
1.6 FTE
Equity
€409,532
Profit
€43,455
Turnover not published (abridged schema)
Financial health
50 Fair Checked score 2024
Bankruptcy chance 12 m
3.4%
Structure
Accounts 64 d overdue0 of 1 deed read
Why 50- Figures for FY 2024 (filed 16-10-2025)- 1 financial year not filed after the legal deadline; latest accounts 76 days late; 2 of the last 3 late- Liquidity: current ratio 1.16, cash €162,201+ Size: 1.6 FTE, total assets €2.2mShow the evidence

Checked score

Score 2024
50 / 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 46% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2023
Average
Solvency 43-6
equity 18.2% of total assets
Liquidity 37-6
short-term debt 45.3% · cash 7.2%
Profitability 71-3
return on assets 1.9%
Bankruptcy probability, 12 months
3.4% Moderate
0%0.5%1.5%4%10%≥ 25%

About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (39,974 companies)
Last 24 months 11-2024: 2.9% 12-2024: 1.3%▼ -57.3% vs 11-2024 01-2025: 1.2%▼ -1.3% vs 12-2024 02-2025: 1.2%● 0.0% vs 01-2025 03-2025: 1.3%▲ +1.1% vs 02-2025 04-2025: 1.3%▲ +0.9% vs 03-2025 05-2025: 1.3%▲ +0.9% vs 04-2025 06-2025: 1.5%▲ +16.9% vs 05-2025 07-2025: 1.6%▲ +6.4% vs 06-2025 08-2025: 2.1%▲ +30.6% vs 07-2025 09-2025: 2.5%▲ +19.6% vs 08-2025 10-2025: 4.0%▲ +61.0% vs 09-2025highest value 11-2025: 1.1%▼ -72.0% vs 10-2025 12-2025: 1.1%▼ -0.8% vs 11-2025 01-2026: 1.0%▼ -6.8% vs 12-2025 02-2026: 1.0%● 0.0% vs 01-2026 03-2026: 1.0%▼ -3.4% vs 02-2026lowest value 04-2026: 1.0%▲ +1.5% vs 03-2026 05-2026: 1.0%▲ +2.0% vs 04-2026 06-2026: 1.2%▲ +15.7% vs 05-2026 07-2026: 1.4%▲ +14.8% vs 06-2026 08-2026: 1.8%▲ +33.8% vs 07-2026 09-2026: 2.1%▲ +16.7% vs 08-2026 10-2026: 3.4%▲ +57.1% vs 09-2026
  • Figures for FY 2024 (filed 16-10-2025) raises the probability
  • 1 financial year not filed after the legal deadline; latest accounts 76 days late; 2 of the last 3 late raises the probability
  • Size: 1.6 FTE, total assets €2.2m lowers the probability for this profile
  • Liquidity: current ratio 1.16, cash €162,201 raises the probability
Credit up to €20,000 at 30 days acceptable
Liquidity tight (current ratio 1.16 against 1.22 in 2023; short-term debt: 45.3% and cash: 7.2% of total assets), and 81.8% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 34%, liquidity 34%, profitability 53%, growth against the median 63%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Figures for FY 2024 (filed 16-10-2025)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · 1 financial year not filed after the legal deadline; latest accounts 76 days late; 2 of the last 3 late
In the bankruptcy model this factor raises the probability.
NBB · filings
lowers risk · Size: 1.6 FTE, total assets €2.2m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
raises risk · Liquidity: current ratio 1.16, cash €162,201
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 15-10-2025, 76 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 8 filings
Deviation from the deadline
2025
not confirmed
2024
76 d late
2023
92 d late
2022
on the day
2021
64 d late
2020
23 d late
2019
35 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 48 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2024 · abbreviated…
  2. Annual accounts filedfiscal year 2023 · abbreviated…
  3. Annual accounts filedfiscal year 2022 · abbreviated…

Key points

  • Caution: Accounts not fileddeadline was 31-07-2026 64 d late View
  • Positive: Company by total assets in Hoeilaart, Wholesale and…in the Checked rankings #10 View
  • Positive: 6 profitable years in a rowprofit 2024: €43,455 6 years View

By topic

Financials

Fiscal year
2024
Total assets
€2.2m
Profit
€43,455
Solvency
18.2%
Total assets▲ 44.4%
Net result
20182024
Go to Financials

Timeline

Events
13
Since
2018
  1. 15-10-2025Annual accounts filed
  2. 31-10-2024Annual accounts filed
  3. 31-07-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
04-08-2016
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure